Â鶹´«Ã½¸ßÇå

Tianjing Li, PhD

Dr. Tianjing Li is a Professor in the Department of Ophthalmology at the University of Â鶹´«Ã½¸ßÇå Denver with a secondary appointment in the Department of Epidemiology at the University of Â鶹´«Ã½¸ßÇå School of Public Health. Previously, Dr. Li worked as an Associate Professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She was a core faculty member in the . The primary goal of Dr. Li’s research is to develop, evaluate, and disseminate efficient methods for comparing healthcare interventions and to provide trustworthy evidence for decision-making. Her research has been funded by the National Institutes of Health, the Patient-Centered Outcomes Research Institute, the Agency for Healthcare Research and Quality, the U.S. Food and Drug Administration, and other national and international public funders.  

Dr. Li has an international reputation for leading methodologic research in systematic review, network meta-analysis, clinical trials, comparative effectiveness research, and patient-centered outcomes research. Evidence of her expertise includes serving as a Co-Editor-in-Chief for the journal , the Reviews Editor for , an Associate Scientific Editor for the 2nd edition of the , a Statistical Editor for , and an author for two reports from the National Academies of Sciences, Engineering, and Medicine.

Dr. Li holds several leadership roles within , including serving as the Associate Director for Cochrane United States from 2012 to 2018, a Coordinating Editor for , a co-convener for the (network meta-analysis methods group), and a Co-Chair of the Cochrane Methods Executive Committee. She was the recipient of the Anne Anderson Award in 2019, being recognized for my cumulative accomplishment, originality, independence of thought, leadership, and inspiration for women within Cochrane. Dr. Li is elected to the , serves as the Society’s President-Elect, and received the Society’s Inaugural Early Career Award in 2016.